Early vs Standard Ileostomy Reversal

May 15, 2026 updated by: Hamza Akhtar, Gulab Devi Hospital

Early Ileostomy Reversal at Two Months Versus Three Months: A Randomized Controlled Trial

This randomized controlled trial compares early (8 weeks) versus standard (12 weeks) ileostomy reversal in patients with confirmed anastomotic healing, evaluating postoperative complications and recovery outcomes.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This open-label randomized controlled trial was conducted at Gulab Devi Teaching Hospital, Lahore, Pakistan, between August 2025 and January 2026 to compare early versus standard timing of ileostomy reversal. Patients aged 14 to 55 years with a protective loop ileostomy following colorectal surgery and radiologically confirmed anastomotic healing were enrolled. Participants were randomized in a 1:1 ratio to undergo ileostomy reversal at approximately 8 weeks (early group) or 12 weeks (standard group).

The primary outcome was the rate of postoperative complications occurring during the index hospital admission following ileostomy reversal. Secondary outcomes included length of hospital stay, time to first oral intake, time to return to normal activities, patient-reported comfort using a visual analogue scale, and 30-day readmission rates.

All procedures were performed using a standardized surgical technique by experienced surgeons within the same unit. Statistical analysis was performed using appropriate tests for continuous and categorical variables, with a significance threshold of p<0.05.

The study aimed to evaluate whether earlier ileostomy reversal is safe and associated with improved recovery outcomes in a resource-limited tertiary care setting.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Gulab Devi Teaching Hospital, Lahore, Pakistan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria

- Age 14-55 years Protective loop ileostomy Radiologically confirmed anastomotic healing

Exclusion Criteria:

  • Colorectal malignancy Abdominal tuberculosis Total colectomy Unfit for anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Reversal
Ileostomy reversal performed at approximately 8 weeks
Surgical closure of loop ileostomy
Active Comparator: Standard Reversal
Ileostomy reversal performed at approximately 12 weeks
Surgical closure of loop ileostomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Postoperative complication rate
Time Frame: From enrollment to end of study at 6 months
From enrollment to end of study at 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Length of hospital stay
Time Frame: From enrollment to the end of study at 6 months
From enrollment to the end of study at 6 months
Time to oral intake
Time Frame: From enrollment to the discharge of patient which was upto 2 weeks
From enrollment to the discharge of patient which was upto 2 weeks
Return to normal activities
Time Frame: From enrollment to end of study at 6 months
From enrollment to end of study at 6 months
Patient comfort score
Time Frame: From enrollment to the discharge of patient which was upto 2 weeks
From enrollment to the discharge of patient which was upto 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Actual)

January 15, 2026

Study Registration Dates

First Submitted

May 5, 2026

First Submitted That Met QC Criteria

May 15, 2026

First Posted (Actual)

May 22, 2026

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 15, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Surgery

Clinical Trials on Ileostomy reversal

Subscribe